News
Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...
GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...
A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-?) ...
Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...
After nearly tripling the company’s value, CEO Lars Fruergaard Jørgensen is preparing to exit amid boardroom shifts. Novo ...
ORLANDO -- Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Many Wall Street analysts think Novo Nordisk will make a solid rebound over the next 12 months. The company may have ...
The drug is set to be available on the NHS for weight loss soon, but one expert has flagged some potential risks that come with it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results